[SYRE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
28-Sep-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -197.32%
YoY-
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 168 174 625 1,362 3,644 1,399 13,696 -94.63%
PBT -18,784 -18,443 -22,314 -24,436 -20,423 -20,281 -6,738 97.70%
Tax 38 -209 9 0 23 26 92 -44.44%
NP -18,822 -18,234 -22,323 -24,436 -20,446 -20,307 -6,830 96.19%
Tax Rate - - - - - - - -
Total Cost 18,990 18,408 22,948 25,798 24,090 21,706 20,526 -5.03%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -11,203.57 -10,479.31 -3,571.68 -1,794.13 -561.09 -1,451.54 -49.87 3559.27%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -7.20 -4.84 -6.79 -9.26 -10.36 -7.72 -2.60 96.83%
EPS Diluted -7.20 -4.84 -6.79 -9.26 -10.36 -7.72 -2.60 96.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.